Adage Capital Partners
MRSN icon

Adage Capital Partners’s Mersana Therapeutics MRSN Stock Holding History

Adage Capital Partners’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,000
Closed -$1.65M – 910
2023
Q2 		$1.65M Buy
+20,000
New +$1.65M ﹤0.01% 748